Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan G Casson

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2007
Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinomaShuo Cheng Zhang, Christie Barclay, Leigh Ann Alexander, et al.
Canadian Respiratory Journal|March 11, 2004
Atypical presentation of lymphomatoid granulomatosis in a patient with longstanding sarcoidosisPaul S Koh, Annette H C Foyle, Yannick Cartier, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective studyAlan G Casson, Susan C Evans, Amy Gillis, et al.
Molecular Carcinogenesis|May 5, 2007
Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinomaMark Baguma-Nibasheka, Christie Barclay, Audrey W Li, et al.
Leukemia Research|February 24, 2005
Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cellsMark Baguma-Nibasheka, Audrey W Li, Mohammed S Osman, et al.
Cancer Letters|July 29, 2004
Microsatellite instability in esophageal adenocarcinomaSusan C Evans, Amy Gillis, Laurette Geldenhuys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense geneChristie Barclay, Audrey W Li, Laurette Geldenhuys, et al.
Cancer Letters|March 15, 2003
ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junctionYasuo Hara, Zuoyu Zheng, Susan C Evans, et al.
Cancer|June 23, 2005
Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
Molecular Carcinogenesis|January 27, 2011
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancerQing-Song Zuo, Ronglin Yan, Dian-Xu Feng, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2007
Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinomaShuo Cheng Zhang, Christie Barclay, Leigh Ann Alexander, et al.
Canadian Respiratory Journal|March 11, 2004
Atypical presentation of lymphomatoid granulomatosis in a patient with longstanding sarcoidosisPaul S Koh, Annette H C Foyle, Yannick Cartier, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective studyAlan G Casson, Susan C Evans, Amy Gillis, et al.
Molecular Carcinogenesis|May 5, 2007
Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinomaMark Baguma-Nibasheka, Christie Barclay, Audrey W Li, et al.
Leukemia Research|February 24, 2005
Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cellsMark Baguma-Nibasheka, Audrey W Li, Mohammed S Osman, et al.
Cancer Letters|July 29, 2004
Microsatellite instability in esophageal adenocarcinomaSusan C Evans, Amy Gillis, Laurette Geldenhuys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense geneChristie Barclay, Audrey W Li, Laurette Geldenhuys, et al.
Cancer Letters|March 15, 2003
ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junctionYasuo Hara, Zuoyu Zheng, Susan C Evans, et al.
Cancer|June 23, 2005
Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
Molecular Carcinogenesis|January 27, 2011
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancerQing-Song Zuo, Ronglin Yan, Dian-Xu Feng, et al.
Pageof 6